Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 27, 2025

October 27, 2025

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

GlobeNewswire

October 27, 2025

Aurora Spine Launches New Biologics Portfolio

GlobeNewswire

October 27, 2025

Elixir Medical anuncia resultados clínicos recientes y significativos sobre el Bioadaptador DynamX® que demuestran una reducción de casi el 50 % en las tasas de acontecimiento coronarios en comparación con el tratamiento de referencia actua

GlobeNewswire

October 27, 2025

Elixir Medical annuncia risultati clinici “late-breaking” significativi per DynamX® Bioadaptor che dimostrano una riduzione vicina al 50% dei tassi di eventi coronarici rispetto all’ attuale standard di cura per l’angioplastica coronarica p

GlobeNewswire

October 27, 2025

Elixir Medical gibt klinische Late-Breaking-Ergebnisse für DynamX® Bioadaptor bekannt, die eine signifikante Reduzierung von koronaren Ereignisraten um nahezu 50 % gegenüber dem aktuellen PCI-Behandlungsstandard zeigen

GlobeNewswire

October 27, 2025

Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX® Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care

GlobeNewswire

October 27, 2025

Elixir Medical annonce de nouveaux résultats cliniques significatifs pour le DynamX® Bioadaptor, démontrant une réduction de près de 50 % des taux d’événements coronariens par rapport à la norme actuelle de soins ICP

GlobeNewswire

October 27, 2025

Elixir Medical ogłasza przełomowe wyniki badań klinicznych DynamX® Bioadaptor – wskazujące na niemal 50% redukcję częstości występowania nieporządanych incydentów wieńcowych w porównaniu do obecnego standardu leczenia PCI

GlobeNewswire

October 27, 2025

Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences

GlobeNewswire

October 27, 2025

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

GlobeNewswire

October 27, 2025

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

GlobeNewswire

October 27, 2025

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

GlobeNewswire

October 27, 2025

MEDIA ADVISORY: Patients join Day of Action at Ontario Legislature to demand action on complaints about private clinics’ charges

GlobeNewswire

October 27, 2025

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

GlobeNewswire

October 27, 2025

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

GlobeNewswire

October 27, 2025

Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

GlobeNewswire

October 27, 2025

IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025

GlobeNewswire

October 27, 2025

Arcutis to Present at Upcoming Investor Conferences

GlobeNewswire

October 27, 2025

Axis Integrated Mental Health Acquires Best Mind to Combat Colorado’s Mental Health Crisis

GlobeNewswire

October 27, 2025

AI’s Transformative Role in Global Markets Highlighted in BCC Pulse Reports

GlobeNewswire